Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00414778|
Recruitment Status : Completed
First Posted : December 22, 2006
Last Update Posted : January 13, 2011
The purpose of this study is to evaluate safety and pharmacokinetics of a single and multiple dose of LHT344 in 12 Chinese healthy subjects.
This study is not recruiting subjects in the United States.
|Condition or disease||Intervention/treatment||Phase|
|Healthy||Drug: LHT344||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||12 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Single-center, Open-label, Single and Multiple Oral Dose Study to Assess Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects|
|Study Start Date :||October 2006|
|Actual Primary Completion Date :||October 2006|
- Pharmacokinetics of single and repeat daily oral dose of LHT344 in Chinese healthy subjects
- Safety of single and repeat daily oral dose of LHT344 in Chinese healthy subjects
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00414778
|Novartis Investigative Site|
|Principal Investigator:||Novartis||Investigator site|